摘要
目的研究化学疗法、放射疗法治疗不能手术的ⅢB期非小细胞肺癌的远期疗效.方法所有病例均给CAP或MVP方案化疗,80例行根治性放疗.结果全组病例1年生存率53.3%（48/90）,3年生存率18.8%（17/90）,5年生存率8.8%（8/90）.鳞癌3年及5年生存率高于腺癌（P＜0.05）.T4T0M03年及5年生存率高于T3N3M0、T4N1～2M0、T4T0M0（P＜0.05～0.01）.结论化疗联合放疗治疗非小细胞肺癌有一定的临床疗效,CAP、MVP两种化疗的3年及5年生存率之间差异无统计学意义.
Objective To study the long-term results of 90 cases with inoperable stage Ⅲ non-small cell lung cancer. Methods All patients received CAP regimen or MVP regimen chemotherapy. 80 patients received radiotherapy. Results The results showed that 1- ,3-,5-year survival rates were 53.4% ,19.5% and 8.5% respectively. The 3-, 5- year survival rate for squamous cell carcinoma were higher than those adenocarcinoma （ P 〈 0.05 ）. The 3-, 5- year survival rate for T4NoMo were higher than those T3N3Mo ,T4N1-2Mo and T4N3Mo（P〈 0.05 -0.01 ）. Conclusion There is no difference in the 3-,5-year survival rate between CAP regimen and MVP regimen.
出处
《中国基层医药》
CAS
2006年第5期768-769,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
癌
非小细胞肺
药物疗法
放射疗法
预后
Carcinoma, non-small-cell lung
Drug therapy
Radiotherapy
Prognosis
